Eli Lilly’s weight loss pill could be just as good as Ozempic — and the stock soars
The first GLP-1 pill could be in medicine cabinets sooner than expected.Read more...
NEWS Online - Medicine
Read More »
Buffy Mischke
01:20
Advances in Existing Drugs and Personalized Therapy Could Help Treat Osteoarthritis
A recent study could help repurpose existing drugs, develop new medicines targeted to broad disease processes, and eventually lead to
In Rural Massachusetts, Patients and Physicians Weigh Trade-Offs of Concierge Medicine
A stressed primary care system has led many doctors to start practices that charge membership fees in exchange for shorter
Lloyd Lanz
11:23
Plastic-eating seabird chicks show signs of organ failure and cognitive decline
For years, Jack Auty studied how inflammation in the human body drives diseases, ranging from stroke to sepsis to Alzheimer’s,
Karolinska Institutet
11:23
Blood Test Predicts Dementia up to 10 Years in Advance, Study Finds
Blood biomarkers like tau217, NfL, and GFAP may predict dementia up to 10 years early, but aren’t yet reliable for
Diana Glebova
04:22
RFK Jr. says HHS will research six ‘environmental factors’ for potential link to autism
Among the "factors" Kennedy said would be scrutinized are ultrasound scans, mold, pesticides, food chemicals, medicines and air and water
Marquis Grumbles
22:21
Full-body scans: are Neko Health and the like more panic than panacea?
Hailed as the 'future of medicine' by some, but not all experts are convinced...
Dual genetic tracing demonstrates the heterogeneous differentiation and function of neuromesodermal progenitors in vivo
Proceedings of the National Academy of Sciences, Volume 122, Issue 14, April 2025. SignificanceNeuromesodermal progenitors (NMPs) play pivotal roles in
Dylan Scott
10:19
We’re on the verge of a universal allergy cure
If you’re bothered by allergies every spring, you may pop a Benadryl or Claritin most mornings to make the days
36Kr English
10:19
Chinese drugmakers weigh options as US mulls pharma tariffs
With Trump floating tariffs on medicine, suppliers are weighing upgrades, relocation, and, for some, the exit. The post Chinese drugmakers
